NovoCure Ltd. (NVCR)
14.99
-0.21
(-1.38%)
USD |
NASDAQ |
Oct 06, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash from Investing (Quarterly) : -6.378M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.378M |
| March 31, 2026 | 7.747M |
| December 31, 2025 | 336.33M |
| September 30, 2025 | 71.44M |
| June 30, 2025 | 35.99M |
| March 31, 2025 | -6.472M |
| December 31, 2024 | -22.21M |
| September 30, 2024 | 10.19M |
| June 30, 2024 | -374.44M |
| March 31, 2024 | 246.22M |
| December 31, 2023 | 98.50M |
| September 30, 2023 | 17.26M |
| June 30, 2023 | -13.90M |
| March 31, 2023 | 82.29M |
| December 31, 2022 | -128.06M |
| September 30, 2022 | -150.24M |
| June 30, 2022 | 155.76M |
| March 31, 2022 | -17.41M |
| December 31, 2021 | -499.09M |
| September 30, 2021 | 302.70M |
| June 30, 2021 | -2.618M |
| March 31, 2021 | 54.17M |
| December 31, 2020 | -613.64M |
| September 30, 2020 | 147.22M |
| June 30, 2020 | -3.315M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.112M |
| December 31, 2019 | -46.76M |
| September 30, 2019 | -2.174M |
| June 30, 2019 | -1.748M |
| March 31, 2019 | -0.989M |
| December 31, 2018 | -1.789M |
| September 30, 2018 | -1.005M |
| June 30, 2018 | -0.842M |
| March 31, 2018 | -1.857M |
| December 31, 2017 | -1.946M |
| September 30, 2017 | -1.753M |
| June 30, 2017 | 0.682M |
| March 31, 2017 | 11.64M |
| December 31, 2016 | -3.396M |
| September 30, 2016 | -4.441M |
| June 30, 2016 | -6.613M |
| March 31, 2016 | 27.44M |
| December 31, 2015 | -126.01M |
| September 30, 2015 | 27.40M |
| June 30, 2015 | -37.94M |
| March 31, 2015 | 21.28M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -34.50M |
| March 31, 2014 | -34.50M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Smith & Nephew plc | -- |
| LivaNova Plc | -31.92M |
| Tristel Plc | -- |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.132M |
| Cash from Financing (Quarterly) | 4.548M |
| Free Cash Flow | -25.43M |
| Free Cash Flow Per Share (Quarterly) | 0.0105 |
| Free Cash Flow to Equity (Quarterly) | 2.736M |
| Free Cash Flow to Firm (Quarterly) | 3.593M |
| Free Cash Flow Yield | -1.49% |